Revised forecast
Fiscal year ending December 2026 · Second quarter (interim period) and full yearPrevious forecast published 13 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
For the interim period, the reasons include the need to newly recognize a provision for shareholder benefits because the increase in the number of eligible shareholders exceeded forecasts and the benefit usage rate exceeded expectations, lower sales due to delays in product manufacturing by 株式会社シーズ・ファクトリー, and a decline in the number of students enrolled in the medical school entrance examination course offered by 株式会社Fujisan Academia Group. For the full year, the reason is the strengthened pursuit of M&A-driven business development and active upfront investment aimed at a swift recovery in performance from 2027 onward.
| Item | Details |
|---|---|
| Net Sales | Second quarter (interim period) 3,135 / Full year 6,276 → Second quarter (interim period) 3,005 / Full year 6,187（Second quarter (interim period) -4.1 / Full year -1.4） |
| Operating profit | Second quarter (interim period) 76 / Full year 174 → Second quarter (interim period) 38 / Full year 81（Second quarter (interim period) -50 / Full year -53.4） |
| Ordinary income | Second quarter (interim period) 73 / Full year 172 → Second quarter (interim period) 38 / Full year 89（Second quarter (interim period) -47.9 / Full year -48.3） |
| Profit attributable to owners of the parent | Second quarter (interim period) 41 / Full year 96 → Second quarter (interim period) 0 / Full year 12（Second quarter (interim period) -100 / Full year -87.5） |
| Net income per share | Second quarter (interim period) ¥12.42 / Full year ¥29.07 → Second quarter (interim period) ¥0.00 / Full year ¥3.63 |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Second quarter (interim period) and full year |
| Publication date of previous forecast | 13 February 2026 |
| Previous-period results | Second quarter (interim period) Net Sales 2,861 / Operating profit 49 / Ordinary income 51 / Interim net income attributable to owners of the parent 20 / Interim net income per share ¥6.32 / Full year Net Sales 5,814 / Operating profit 162 / Ordinary income 168 / Profit attributable to owners of the parent 79 / Net income per share ¥23.99 |
| Reason for the revision | For the interim period, the reasons include the need to newly recognize a provision for shareholder benefits because the increase in the number of eligible shareholders exceeded forecasts and the benefit usage rate exceeded expectations, lower sales due to delays in product manufacturing by 株式会社シーズ・ファクトリー, and a decline in the number of students enrolled in the medical school entrance examination course offered by 株式会社Fujisan Academia Group. For the full year, the reason is the strengthened pursuit of M&A-driven business development and active upfront investment aimed at a swift recovery in performance from 2027 onward. |
| Dividend forecast revision | No change. The initial forecast of ¥16 per share remains unchanged. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the interim period, the reasons include the need to newly recognize a provision for shareholder benefits because the number of eligible shareholders and the benefit usage rate exceeded expectations, lower sales due to delays in product manufacturing by 株式会社シーズ・ファクトリー, and a decline in the number of students enrolled in the medical school entrance examination course offered by 株式会社Fujisan Academia Group. For the full year, the reason is the active pursuit of M&A-driven business development and upfront investment aimed at recovering performance from 2027 onward.